Replies to post #211142 on Biotech Values

[DewDiligence]

HZNP—FDA approves Tepezza for Thyroid Eye Disease—a rare disease:

https://finance.yahoo.com/news/fda-approves-tepezzatm-teprotumumab-trbw-200400211.html

This is the drug HZNP picked up in its 2017 buyout of River Vision for $145M (#msg-131172440).